[1]
H. L. Couto, “Cost-effectiveness analysis and budget impact analysis of next-generation sequencing panel including BRCA1 and BRCA2 genes for women diagnosed with non-metastatic breast cancer in Brazil”, MAST, vol. 35, no. suppl.1, Feb. 2026.